• British Pharmacopoeia Volume I & II
  • Monographs: Medicinal and Pharmaceutical Substances

Acetylcysteine

European Union chaplet of stars
scroll to previous hit
scroll to next hit
General Notices

(Ph. Eur. monograph 0967)

bp2013_v1_07_medicinal_and_pharmaceutical_substances_01 acetylcysteine_1_2012_70_cs.png


C 5 H 9 NO 3 S    163.2     616-91-1

Action and use

Sulfydryl donor; antidote to paracetamol poisoning; mucolytic.

Preparation

Acetylcysteine Injection

Ph Eur

DEFINITION

(2R)-2-(Acetylamino)-3-sulfanylpropanoic acid.

Content

98.0 per cent to 101.0 per cent (dried substance).

CHARACTERS
Appearance

White or almost white, crystalline powder or colourless crystals.

Solubility

Freely soluble in water and in ethanol (96 per cent), practically insoluble in methylene chloride.

IDENTIFICATION

First identification    A, C.

Second identification    A, B, D, E.

A. Specific optical rotation (see Tests).

B. Melting point (2.2.14): 104 °C to 110 °C.

C. Infrared absorption spectrophotometry (2.2.24).

Preparation    Discs of potassium bromide R.

Comparison    acetylcysteine CRS.

D. Examine the chromatograms obtained in the test for related substances.

Results    The principal peak in the chromatogram obtained with test solution (b) is similar in retention time and size to the principal peak in the chromatogram obtained with reference solution (b).

E. To 0.5 mL of solution S (see Tests) add 0.05 mL of a 50 g/L solution of sodium nitroprusside R and 0.05 mL of concentrated ammonia R. A dark violet colour develops.

TESTS
Solution S

Dissolve 1.0 g in carbon dioxide-free water R and dilute to 20 mL with the same solvent.

Appearance of solution

Solution S is clear (2.2.1) and colourless (2.2.2, Method II).

pH (2.2.3)

2.0 to 2.8.

To 2 mL of solution S add 8 mL of carbon dioxide-free water R and mix.

Specific optical rotation (2.2.7)

+ 21.0 to + 27.0 (dried substance).

In a 25 mL volumetric flask, mix 1.25 g with 1 mL of a 10 g/L solution of sodium edetate R. Add 7.5 mL of a 40 g/L solution of sodium hydroxide R, mix and dissolve. Dilute to 25.0 mL with phosphate buffer solution pH 7.0 R2.

Related substances

Liquid chromatography (2.2.29). Except where otherwise prescribed, prepare the solutions immediately before use.

Test solution (a)    Suspend 0.80 g of the substance to be examined in 1 mL of 1 M hydrochloric acid and dilute to 100.0 mL with water R.

Test solution (b)    Dilute 5.0 mL of test solution (a) to 100.0 mL with water R. Dilute 5.0 mL of this solution to 50.0 mL with water R.

Test solution (c)    Use test solution (a) after storage for at least 1 h.

Reference solution (a)    Suspend 4.0 mg of acetylcysteine CRS, 4.0 mg of l-cystine R (impurity A), 4.0 mg of l-cysteine R (impurity B), 4.0 mg of acetylcysteine impurity C CRS and 4.0 mg of acetylcysteine impurity D CRS in 1 mL of 1 M hydrochloric acid and dilute to 100.0 mL with water R.

Reference solution (b)    Suspend 4.0 mg of acetylcysteine CRS in 1 mL of 1 M hydrochloric acid and dilute to 100.0 mL with water R.

Column:
  • sizel = 0.25 m, Ø = 4 mm;

Mobile phase    Stir 3 volumes of acetonitrile R and 97 volumes of water R in a beaker; adjust to pH 3.0 with phosphoric acid R.

Flow rate    1.0 mL/min.

Detection    Spectrophotometer at 220 nm.

Injection    20 µL, 3 times; inject 0.01 M hydrochloric acid as a blank.

Run time    5 times the retention time of acetylcysteine (about 30 min).

Retention time    Impurity A = about 2.2 min; impurity B = about 2.4 min; 2-methyl-2-thiazoline-4-carboxylic acid, originating in test solution (c) = about 3.3 min; acetylcysteine = about 6.4 min; impurity C = about 12 min; impurity D = about 14 min.

System suitability    Reference solution (a):

  • resolution: minimum 1.5 between the peaks due to impurities A and B and minimum 2.0 between the peaks due to impurities C and D.

From the chromatogram obtained with test solution (a), calculate the percentage content of the known impurities (T1) and the unknown impurities (T2) using the following equations:

bp2013_v1_07_medicinal_and_pharmaceutical_substances_01 acetylcysteine_2_2012_70_eq.png


A 1

=

peak area of individual impurity (impurity A, impurity B, impurity C and impurity D) in the chromatogram obtained with test solution (a);

A 2

=

peak area of the corresponding individual impurity (impurity A, impurity B, impurity C and impurity D) in the chromatogram obtained with reference solution (a);

A 3

=

peak area of unknown impurity in the chromatogram obtained with test solution (a);

A 4

=

peak area of acetylcysteine in the chromatogram obtained with reference solution (b);

m 1

=

mass of the substance to be examined in test solution (a);

m 2

=

mass of the individual impurity in reference solution (a);

m 3

=

mass of acetylcysteine in reference solution (b).

Limits:
  • impurities A, B, C, D: for each impurity, maximum 0.5 per cent;
  • any other impurity: for each impurity, maximum 0.5 per cent;
  • total: maximum 0.5 per cent;
  • disregard limit: 0.1 times the area of the principal peak in the chromatogram obtained with reference solution (b) (0.05 per cent); disregard any peak with a retention time of about 3.3 min due to 2-methyl-2-thiazoline-4-carboxylic acid.
Heavy metals (2.4.8)

Maximum 10 ppm.

2.0 g complies with test C. Prepare the reference solution using 2 mL of lead standard (10 ppm Pb) R.

Zinc

Maximum 10 ppm.

Atomic absorption spectrometry (2.2.23, Method II).

Test solution    Dissolve 1.00 g in 0.001 M hydrochloric acid and dilute to 50.0 mL with the same acid.

Reference solutions    Prepare the reference solutions using zinc standard solution (5 mg/mL Zn) R, diluting with 0.001 M hydrochloric acid.

Source    Zinc hollow-cathode lamp.

Wavelength    213.8 nm.

Atomisation device    Air-acetylene flame.

Use a correction procedure for non-specific absorption.

Loss on drying (2.2.32)

Maximum 1.0 per cent, determined on 1.000 g by drying in an oven in vacuo at 70 °C for 3 h.

Sulfated ash (2.4.14)

Maximum 0.2 per cent, determined on 1.0 g.

ASSAY

Dissolve 0.140 g in 60 mL of water R and add 10 mL of dilute hydrochloric acid R. After cooling in iced water, add 10 mL of potassium iodide solution R and titrate with 0.05 M iodine, using 1 mL of starch solution R as indicator.

1 mL of 0.05 M iodine is equivalent to 16.32 mg of C5H9NO3S.

STORAGE

Protected from light.

IMPURITIES

Specified impurities    A, B, C, D.

bp2013_v1_07_medicinal_and_pharmaceutical_substances_01 acetylcysteine_3_2012_70_cs.png


A. 3,3′-disulfanediylbis[(2R)-2-aminopropanoic acid] (l-cystine),

bp2013_v1_07_medicinal_and_pharmaceutical_substances_01 acetylcysteine_4_2012_70_cs.png


B. (2R)-2-amino-3-sulfanylpropanoic acid (l-cysteine),

bp2013_v1_07_medicinal_and_pharmaceutical_substances_01 acetylcysteine_5_2012_70_cs.png


C. (2R,2′R)-3,3′-disulfanediylbis[2-(acetylamino)propanoic acid] (N,N′-diacetyl-l-cystine),

bp2013_v1_07_medicinal_and_pharmaceutical_substances_01 acetylcysteine_6_2012_70_cs.png


D. (2R)-2-(acetylamino)-3-(acetylsulfanyl)propanoic acid (N,S-diacetyl-l-cysteine).

Ph Eur